This article is more than 5 years old. Information may no longer be current.

VIDEO: Gene mutation analysis an ‘important piece’ of melanoma diagnosis

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

NEW YORK — Klaus J. Busam, MD, director of the dermatopathology service at Memorial Sloan Kettering Cancer Center, highlighted the role of molecular profiling in melanoma diagnosis during his presentation at HemOnc Today Melanoma and Cutaneous Malignancies.

Busam focused on studies designed to evaluate gene mutation analysis for melanoma diagnosis. Topics included the use of gene mutation analysis in determining the distinction between melanoma and sarcoma, staging of primary melanoma vs. metastatic disease, and concerns in diagnosing melanoma vs. nevus.

“Mutation alone doesn’t give you the answer,” Busam said. “Mutations do not have a tight association with the phenotype. You need to put it in context with clinical and histopathologic data to make the right diagnosis. In essence, molecular studies can be an important piece of the diagnostic puzzle.”

Reference:

Busam K. The role of molecular profiling in melanoma diagnosis. Presented at: HemOnc Today Melanoma and Cutaneous Malignancies; March 24-25, 2017; New York.

Disclosure: Busam reports no relevant financial disclosures.